Drawing for CONSILIAS

USPTO serial 79403310

CONSILIAS

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
RADEMACHER, APRIL LUEDERS
Law office
TMEG LAW OFFICE 108

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with CONSILIAS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
009Supply chain management software for cell and gene therapy and advanced therapies; software integration for supply chain management; software including medical and science; data management software for clinical trials; software for chain of identity and chain of custody management; application software for cloud computing services; software for the purpose of business and maintenance; software databases for the purposes of recording storage and processing of data; data storage apparatus; reporting software; software; cloud-based and cloud server; interactive business and database software; databases; training software; software for product development; artificial intelligence for analysis and reporting; artificial intelligence for healthcare.ACTIVE—
035Electronic data processing services including the collection of data for business purposes relating to health care information; computer database management services; data management services; data collection; data collection services; collection of data; commercial data analysis.ACTIVE—
041Training in the operation and development of software systems; training relating to development in the field of cell and gene therapy; general training; training and further training consultancy; training sessions; training and instruction; personnel training; training courses; staff training services; business training.ACTIVE—
042Non-downloadable computer software in the medical sector including for cell and gene therapy orchestration; software as a service (SaaS) for business purposes; software as a service for cell and gene therapy orchestration; software as a services to schedule and plan pharmaceutical resources; software platforms for health data storage; control and tracking of cell and gene therapy products; software maintenance services; software as a service for management; control and tracking of cell and gene therapy products; platform as a service for cell and gene therapy orchestration; platform as a service to schedule and plan pharmaceutical resources; platform as a service for management; data as a service; software development services; consulting services in the field of software as a service; software customisation services; software for the purposes of consultancy and repair; platform software for business purposes; electronic data storage including data logs; online data storage services for the purposes of archiving databases; design and development of systems for data input, output, processing, display and storage; development of operating system software; software as a service featuring software for deep learning; technology consultation in the field of artificial intelligence; data authentication via blockchain; data storage via blockchain; validation and integrity of data via blockchain.ACTIVE—
045Software licensing for cell and gene therapy orchestration solution; software licensing to schedule and plan pharmaceutical resources; licensing of databases; granting of software licences to users.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 17, 2026FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 28, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 28, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Feb 12, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jan 27, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 27, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Sep 3, 2025MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Aug 28, 2025ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Mar 1, 2025RFNTREFUSAL PROCESSED BY IB—
Feb 13, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 13, 2025RFRRREFUSAL PROCESSED BY MPU—
Jan 7, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 6, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 5, 2024DOCKASSIGNED TO EXAMINER—
Sep 4, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 4, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 29, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance